Trial results 31 January 2024 Novartis calls time on TIM-3 and HIF2α The company’s move could be a warning for rivals including GSK, AstraZeneca and Incyte. Read more
Trial results 1 September 2023 Roche could take another targeted treatment into adjuvant lung cancer Read more